Dimerization of [Fe^III(bpy)₃]³⁺ in Aqueous Solutions: Elucidating a Mechanism Based on Historical Proposals, Electrochemical Data, and Computationa... by Nicolas E. Holubowitch (9254254)

“…Despite these favorable characteristics, its oxidized Fe­(III) form undergoes dimerization to form μ-O-[Fe^III(bpy)₂(H₂O)]₂⁴⁺, leading to a dramatic ∼0.7 V decrease during battery discharge. …”

Immunofluorescence analysis for F-actin in RPTECs infected with Oki53 and Oki65 at 24 h post-infection. by Tetsuya Kakita (4922584)

DNMT1 knock down decreases HDAC1 binding to RGS10 promoters in chemoresistant ovarian cancer cells. by Ercan Cacan (393523)

SARS-CoV-2 induced lung inflammation is increased with IL-10 blockade and decreased with IFNγ blockade. by Christine E. Nelson (18946410)

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)

Systemic inhibition of CSF-1R decreases B16F10-induced accumulation of blood monocyte subsets. by Marjolein Sluijter (613087)

Image 10_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

Hypothetical model representing the distinct strategies of epithelial barrier disruption by Oki strains. by Tetsuya Kakita (4922584)

RvD1 decreases production of pro-inflammatory mediators in BALF and total lung homogenate but increases IL-10. by Hsi-Min Hsiao (385810)

Metformin lotion decreases TGF-β1 levels in the wounded skin of rats after 10 days of wound healing. by Jianying Zhang (256508)

One-step growth cycle of CVB3 wild type and M1-M6 mutant viruses in HeLa cells. by Jawhar Gharbi (11492361)

<i>sox10</i> mutants have decreased intestinal transit and hyperpermeability, independent of intestinal microbially induced inflammation. by M. Kristina Hamilton (9162785)

The change in value of the Kruskal-Wallis H Test for the first 10 components of the Blood PCA as the platform-variance threshold is decreased. by Paul W. Angel (9427740)

Mast cell density and tactile sensitivity decreased after 10 preventative imatinib treatments followed by repeated MI challenges. by Jaclyn M. Kline (9565161)

“…<p>For preventative imatinib treatment, mice were treated with 100 μL of 30 mg/kg imatinib dissolved in 0.9% saline injected intraperitoneally 30 minutes before each of 10 daily MI challenges. (A) Density of avidin⁺ mast cells in 10 μm labiar skin cryo-sections from sensitized mice receiving NT or preventatively treated with imatinib and challenged 10 times daily with MI. …”

AAMs compared to CAMs show decreased CCL13 expression and increased IL-10 production post BCG infection. by Soumya Chatterjee (473957)

A targeted RNAi screen identifies 17 RNAi candidates that decrease the prolonged lifespan of the METC mutant <i>isp-1;ctb-1</i> by at least 10%. by Ludivine Walter (216669)

“…Among them, 13 represent transcription factors not previously known to function in aging and four (indicated with asterisks) are transcription factors already known to affect lifespan in <i>C. elegans</i>: HSF-1 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Hsu1" target="_blank">[31]</a>, NHR-49 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-VanGilst1" target="_blank">[32]</a>, DAF-16 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Kenyon1" target="_blank">[33]</a>, and PHA-4 <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001084#pbio.1001084-Panowski1" target="_blank">[34]</a>. …”

ARF6 knockdown increases glucosylceramide levels and decreases sphingomyelin levels in Neuro-2a cells. by Lu Li (14069)

Effect of decreased cell numbers on metabolite peak intensities. by Venugopal Gunda (492731)

Effects on the probability to choose the larger-but-later (LL) option in the temporal discounting task (N = 28) from a generalized mixed effects regression analysis (glmer model: c... by David Mathar (9707947)

Pharmacological inhibition and/or siRNA silencing of EP2 receptor in EP2S cells decrease claudin-4 expression. by Manigandan Lejeune (458492)